Related Resources

Webinar: Looking to the Future: What’s next in Antibody Therapeutics

At the 2021 AE&T EU conference, Tracey Mullens, CEO of Abveris, and Brian Walters, CEO of Genovac, joined John Proctor, SVP Antibody Therapeutics, for a discussion about the evolving landscape of antibody therapeutics, the technologies they have turned to address today’s complex targets, and how they are preparing for tomorrow’s challenges.

Antibody Discovery

Webinar: Antibody Discovery – Select Better Lead Candidates in Under 1 Week

Learn how we enable lead candidate down-selection in 1 day by performing functional characterization during primary screening. Case studies highlight how our customers are dramatically accelerating development of next-generation antibody therapeutics.

Antibody Discovery

Application Note: Accessing Greater Antibody Sequence Diversity

See how you can discover >5,000 antigen-specific hits from a single plasma B cell sample and recover >650 unique BCR sequences in under 1 week.